- Home
- DSGR vs TVTX Comparison
DSGR vs TVTX Comparison
Compare DSGR & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGR
- TVTX
- Stock Information
- Founded
- DSGR 1952
- TVTX 2008
- Country
- DSGR United States
- TVTX United States
- Employees
- DSGR N/A
- TVTX N/A
- Industry
- DSGR Industrial Machinery/Components
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- DSGR Industrials
- TVTX Health Care
- Exchange
- DSGR Nasdaq
- TVTX Nasdaq
- Market Cap
- DSGR 1.4B
- TVTX 1.5B
- IPO Year
- DSGR N/A
- TVTX N/A
- Fundamental
- Price
- DSGR $33.26
- TVTX $17.92
- Analyst Decision
- DSGR Buy
- TVTX Strong Buy
- Analyst Count
- DSGR 1
- TVTX 16
- Target Price
- DSGR $39.00
- TVTX $33.40
- AVG Volume (30 Days)
- DSGR 61.2K
- TVTX 1.5M
- Earning Date
- DSGR 07-31-2025
- TVTX 08-06-2025
- Dividend Yield
- DSGR N/A
- TVTX N/A
- EPS Growth
- DSGR N/A
- TVTX N/A
- EPS
- DSGR 0.08
- TVTX N/A
- Revenue
- DSGR $1,928,948,000.00
- TVTX $333,865,000.00
- Revenue This Year
- DSGR $10.80
- TVTX $71.61
- Revenue Next Year
- DSGR $4.10
- TVTX $43.45
- P/E Ratio
- DSGR $360.86
- TVTX N/A
- Revenue Growth
- DSGR 13.48
- TVTX 87.94
- 52 Week Low
- DSGR $21.87
- TVTX $8.46
- 52 Week High
- DSGR $41.47
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- DSGR 66.98
- TVTX 59.60
- Support Level
- DSGR $31.50
- TVTX $17.24
- Resistance Level
- DSGR $32.94
- TVTX $19.08
- Average True Range (ATR)
- DSGR 0.90
- TVTX 0.87
- MACD
- DSGR 0.05
- TVTX 0.04
- Stochastic Oscillator
- DSGR 89.98
- TVTX 66.67
About DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education and medical industries.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.